Aulisa Medical USA, Inc.

Based in California, US, and founded in 2012, Aulisa Medical USA, Inc. , also known as Aulisa is a developer of wearable medical devices, intended to continuously monitor the vitals of adults, infants, or other patients remotely. In January 2022, the company raised USD 13 million in series A funding. As of 2022, the firm is being led by its founder, Chairman, and CEO, Augie Lien, and it operates as a wholly-owned subsidiary of Taiwan Aulisa Medical Devices Technologies, Inc.

Aulisa Medical USA, Inc. develops and offers wireless, wearable vital measuring devices, that facilitate continuous remote monitoring of heartbeat, blood oxygen levels, and other vitals in adults, and infants, both in and out of the hospital setting. The company’s flagship product, Guardian Angel® Rx Vital Sign Monitoring Systems, comes with features such as cloud-based, patient monitoring audio/video, and alarm systems, etc, and its proprietary technology measures vitals continuously, and whenever the vitals cross a pre-set value, the system will notify and alarm caregivers or hospital professionals, allowing them to make necessary lifesaving interventions at the appropriate time. The firm's solutions reduce the amount of time and effort involved in doing regular on-the-spot vital checks, and its incident data recording allows doctors to analyze and improve their care.

Aulisa Medical USA, Inc. will use the funds to meet the rapidly increasing market demand and support its high-speed business growth to empower consumers and healthcare providers with smart medical and IT technologies that can detect adverse events and potentially save lives.